| ISO 17043 (I) | ||
| Homogeneity and stability testing | -- | Wim Coucke |
| The perspective of the accreditation body | -- | Martin Stearn |
| The ISO17043 from the perspective of Laboratory Medicine: Do we need a revision? (results of a questionnaire + discussion) | -- | Piet Meijer |
| Abstract presentations (I) | ||
| Development of Belgian guidelines for the minimal frequency of participation to method and disease-based genetic proficiency testing in the context of hereditary rare diseases | -- | Joséphine Lantoine | Weqas INR Programme – An Example of Post Market Vigilance | -- | Samantha Jones |
| Adam Uldall Lecture | ||
| EQA– future challenges and opportunities | -- | Annette Thomas |
| Molecular Genetics | ||
| The effect of global migration on the European population genotype | -- | Dorret Boomsma |
| EQA in genetic testing | -- | Fiona Morgan |
| EQALM collaborations | ||
| Harmonisation and traceability: a global effort (introduction + discussion) | -- | Sverre Sandberg and Eline van der Hagen |
| Quality of interpretative comments | -- | Eva Ajzner |
| Introduction on the Task and Finishing group on Immunology | -- | Dina Patel |
| ISO 17043 (II) | ||
| Commutability of EQA samples, how to assess | -- | Vincent Delatour |
| Abstract presentations (II) | ||
| Contribution from local organizer, SNEQAS | -- | Saša Bratož |
| ProMeQuaLab - Project of Laboratory Quality Improvement for Portuguese Speaking Countries. Tasks during 2015-2019 | -- | Ana Faria |
